SciELO - Scientific Electronic Library Online

 
vol.79 issue4Alcohol takes its toll on Europe’s youth author indexsubject indexarticles search
Home Page  

Bulletin of the World Health Organization

Print version ISSN 0042-9686

Bull World Health Organ vol.79 n.4 Genebra Jan. 2001

http://dx.doi.org/10.1590/S0042-96862001000400024 

WHO News


In Brief

WHO airline meeting sparks deep thrombosis research

A mid-March meeting of experts and airline representatives convened by the WHO concluded that ‘‘a link probably exists between air travel and deep vein thrombosis’’ but that evidence is lacking to determine the magnitude of the problem. The meeting participants decided to launch three large-scale studies to quantify the link, to identify precipitating factors and to examine possible preventive measures. The studies will be coordinated by the WHO and the International Civil Aviation Organization.

 

Further information from Mr Gregory Hartl,
WHO, email: hartlg@who.int;
fax: (+41 22) 791 4858


New anti-malarial drug should outsmart parasite resistance

The WHO and the pharmaceutical firm GlaxoSmithKline (GSK) announced in March that they had linked up to develop a new antimalarial combination drug, called LAPDAP. The drug, which is given orally, combines two existing antimalarial compounds, chlorproguanil and dapsone, and will be offered to public health programmes at a preferential price. Clinical trials in Africa have shown the drug to be effective in uncomplicated malaria resistant to other standard antimalarials. To further protect the new combination drug from parasite resistance, the partnership plans eventuallyto equip it with a third antimalarial drug, artemisinin.

 

Further information from Mr Gregory Hartl,
WHO, email: hartlg@who.int;
fax: (+41 22) 791 4858